Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 18, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	63	27	15	16	28	28
Market Cap Growth	86.22%	81.79%	-9.41%	-41.33%	0.13%	628.25%
Enterprise Value	34	23	12	7	25	24
Last Close Price	0.12	0.07	0.07	0.08	0.14	0.25
PS Ratio	12.55	7.18	3.36	13.86	14.17	18.31
PB Ratio	1.46	1.29	1.31	1.04	1.29	2.72
P/TBV Ratio	1.80	2.08	4.29	2.09	2.02	11.69
EV/Sales Ratio	6.81	5.99	2.59	5.99	12.57	15.85
Debt / Equity Ratio	0.01	0.00	0.14	0.14	0.10	-
Net Debt / Equity Ratio	-0.67	-0.52	-0.16	-0.44	-0.57	-0.18
Net Debt / EBITDA Ratio	3.46	1.60	0.39	1.11	3.44	0.79
Net Debt / FCF Ratio	2.15	1.58	0.35	1.32	2.83	0.63
Asset Turnover	0.17	0.20	0.27	0.06	0.11	0.15
Quick Ratio	27.76	7.75	1.93	3.78	31.03	5.28
Current Ratio	28.17	7.91	1.98	3.82	31.18	5.45
Return on Equity (ROE)	-28.49%	-40.51%	-33.05%	-33.13%	-22.64%	-24.08%
Return on Assets (ROA)	-17.71%	-22.47%	-17.04%	-18.20%	-12.88%	-14.63%
Return on Capital Employed (ROCE)	-19.20%	-32.30%	-39.90%	-39.40%	-15.20%	-22.60%
Earnings Yield	-12.62%	-24.20%	-30.15%	-37.85%	-12.96%	-8.13%
FCF Yield	-21.30%	-25.36%	-34.34%	-32.18%	-15.71%	-10.41%
Buyback Yield / Dilution	-75.83%	-58.35%	-0.02%	-33.27%	-53.71%	-95.36%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.